| 8 | Pharmaceutical PreparationsIBA
01/2021
-
01/2007 |
| 4 | Proteins (Proteins, Gene)FDA Link
01/2022
-
07/2002 |
| 3 | Biomarkers (Surrogate Marker)IBA
01/2018
-
11/2006 |
| 3 | Oxidoreductases (Dehydrogenase)IBA
12/2016
-
01/2013 |
| 2 | Isoniazid (Ftivazide)FDA LinkGeneric
01/2017
-
11/2015 |
| 2 | Phenyl EthersIBA
12/2016
-
01/2014 |
| 2 | Acyl Carrier ProteinIBA
06/2014
-
01/2013 |
| 2 | BenzimidazolesIBA
05/2014
-
01/2014 |
| 1 | (11R,13S,17S)- 11- (1,3- benzodioxol- 5- yl)- 17- hydroxy- 13- methyl- 17- prop- 1- ynyl- 1,2,6,7,8,11,12,14,15,16- decahydrocyclopenta(a)phenanthren- 3- oneIBA
01/2022 |
| 1 | Angiotensin-Converting Enzyme 2IBA
01/2022 |
| 1 | AndrogensIBA
01/2022 |
| 1 | GlucocorticoidsIBA
01/2022 |
| 1 | Membrane Proteins (Integral Membrane Proteins)IBA
01/2022 |
| 1 | Androgen Receptors (Androgen Receptor)IBA
01/2022 |
| 1 | Serine Proteases (Serine Protease)IBA
01/2022 |
| 1 | TriterpenesIBA
11/2021 |
| 1 | betulinIBA
11/2021 |
| 1 | lupaneIBA
11/2021 |
| 1 | DNA Topoisomerase IV (Topoisomerase IV)IBA
10/2021 |
| 1 | DNA GyraseIBA
10/2021 |
| 1 | NeurotoxinsIBA
01/2021 |
| 1 | Anti-Bacterial Agents (Antibiotics)IBA
01/2021 |
| 1 | ManganeseIBA
01/2021 |
| 1 | Complement System Proteins (Complement)IBA
01/2018 |
| 1 | isonicotinyl-NADIBA
01/2017 |
| 1 | SolventsIBA
12/2016 |
| 1 | LipidsIBA
12/2016 |
| 1 | Dinoprostone (PGE2)FDA Link
10/2016 |
| 1 | Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2016 |
| 1 | tolfenamic acidIBA
10/2016 |
| 1 | Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2016 |
| 1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2016 |
| 1 | 2-hydroxypyridineIBA
06/2014 |
| 1 | CG 400549IBA
06/2014 |
| 1 | Ether (Diethyl Ether)IBA
04/2014 |
| 1 | DNA (Deoxyribonucleic Acid)IBA
01/2013 |
| 1 | Fatty Acids (Saturated Fatty Acids)IBA
01/2013 |
| 1 | EstersIBA
11/2011 |
| 1 | Coenzyme A (CoA)IBA
11/2011 |
| 1 | Vitamin K 2 (Vitamin K2)IBA
11/2011 |
| 1 | Silver Sulfadiazine (SSD)FDA LinkGeneric
04/2011 |
| 1 | Glycoproteins (Glycoprotein)IBA
02/2011 |
| 1 | Antitubercular AgentsIBA
11/2010 |
| 1 | Biological ProductsIBA
05/2009 |
| 1 | AerosolsIBA
04/2009 |
| 1 | EnzymesIBA
03/2009 |
| 1 | ElementsIBA
11/2006 |
| 1 | Recombinant ProteinsIBA
11/2006 |
| 1 | GlycolipidsIBA
11/2006 |
| 1 | AntigensIBA
11/2006 |
| 1 | Mycolic Acids (Mycolic Acid)IBA
12/2003 |
| 1 | 1-Butanol (n Butanol)IBA
03/2003 |
| 1 | Ethambutol (Myambutol)FDA LinkGeneric
03/2003 |
| 1 | ethylenediamine (ethylenediamine dihydroiodide)FDA Link
03/2003 |
| 1 | Oxygen (Dioxygen)IBA
07/2002 |
| 1 | Peptides (Polypeptides)IBA
07/2002 |